Skip to main content
SpringerLink
Log in

The value of time-intensity curves obtained after microbubble contrast agent injection to discriminate responders from non-responders to anti-inflammatory medication among patients with Crohn’s disease

  • Gastrointestinal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To assess the value of time-intensity curves obtained after sulphur hefluoride-filled microbubble contrast agent injection to discriminate responders from non-responders among patients with Crohn’s disease (CD).

Methods

Forty-three patients (29 male and 14 female; mean age ± SD, 48.5 ± 17.17 years) with initial diagnosis of active CD were recruited. In each patient, the therapeutic outcome was assessed after 12 weeks from the beginning of pharmacologic treatment. The terminal ileal loop was scanned after sulphur hexafluoride-filled microbubble injection, and the digital cine-clip registered during the first-pass dynamic enhancement was quantified in gray-scale levels. The percentage of maximal enhancement, time to peak enhancement, and area under the time-intensity curve in responders vs. non-responders were compared by Mann-Whitney U non-parametric test.

Results

Responders (n = 25 patients) vs. non-responders (n = 18) differed in the area under the time-intensity curve (621.58 ± 374.53 vs. 1,199.64 ± 386.39 P < 0.05), while they did not differ in percentage of maximal enhancement (41.26 ± 15.22 vs. 43.17 ± 4.41, P = 0.25) and time to peak enhancement (11.31 ± 3.06 vs. 10.12 ± 3.47, P = 0.15).

Conclusions

The area under the time-intensity curve obtained after microbubble injection was the only parameter to discriminate responders from non-responders among patients with CD during pharmacologic treatment.

Key Points

• Dynamic ultrasound using microbubble contrast agents can help assess inflammatory bowel disease

• Time-intensity curves can assess therapeutic outcome in Crohn’s disease (CD)

• The area under the time-intensity curve differentiates responders from non-responders during pharmacological treatment

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

CD:

Crohn’s disease

CDAI:

Crohn’s disease activity index

CEUS:

contrast-enhanced US

References

  1. Quinn PG, Binion DG, Connors PJ (2001) Radiologic and endoscopic diagnosis of Crohn’s disease. Surg Clin North Am 81:39–70

    Article  Google Scholar 

  2. Paulsen SR, Huprich JE, Fletcher JG et al (2006) CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. RadioGraphics 26:641–657

    Article  PubMed  Google Scholar 

  3. Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn’s disease. RadioGraphics 30:367–384

    Article  PubMed  Google Scholar 

  4. Rimola J, Ordás I, Rodríguez S, Ricart E, Panés J (2011) Imaging indexes of activity and severity for Crohn’s disease: current status and future trends. Abdom Imaging. doi:10.1007/s00261-011-9820-z

  5. Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. Gastroenterology 70:439–444

    PubMed  CAS  Google Scholar 

  6. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 14:1017–1024

    Article  PubMed  Google Scholar 

  7. Sempere GAJ, Martinez Sanjuan V, Medina Chulia E et al (2005) MRI evaluation of inflammatory activity in Crohn’s disease. Am J Roentgenol 184:1829–1835

    Article  Google Scholar 

  8. Bodily KD, Fletcher JG, Solem CA et al (2006) Crohn’s disease: mural attenuation and thickness at contrast-enhanced CT enterography—correlation with endoscopic and histologic findings of inflammation. Radiology 238:505–516

    Article  PubMed  Google Scholar 

  9. Martínez MJ, Ripollés T, Paredes JM, Blanc E, Martí-Bonmatí L (2009) Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRI. Adom Imaging 34:141–148

    Article  Google Scholar 

  10. Leyendecker JR, Bloomfeld RS, DiSantis DJ, Waters GS, Mott R, Bechtold RE (2009) MR enterography in the management of patients with Crohn’s disease. Radiographics 29:1827–1846

    Article  PubMed  Google Scholar 

  11. Guidi L, De Franco A, De Vitis I et al (2006) Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn’s disease. Eur Rev Med Pharmacol Sci 10:23–26

    PubMed  CAS  Google Scholar 

  12. Pauls S, Gabelmann A, Schmidt SA et al (2006) Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound. Eur Radiol 16:2410–2417

    Article  PubMed  Google Scholar 

  13. Migaleddu V, Scanu AM, Quaia E et al (2009) Contrast-enhanced ultrasonography evaluation of inflammatory activity in Crohn’s disease. Gastroenterology 137:43–61

    Article  PubMed  Google Scholar 

  14. Ripollés T, Martínez MJ, Paredes JM, Blanc E, Flors L, Delgado F (2009) Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 253:241–248

    Article  PubMed  Google Scholar 

  15. De Franco A, Di Veronica A, Armuzzi A et al (2012) Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity. Radiology 262:680–688

    Article  PubMed  Google Scholar 

  16. WORLD medical association declaration of Helsinki: ethical principles for medical research involving human subjects, 2008 (last access April 2012) http://www.wma.net/en/30publications/10policies/b3/index.html)

  17. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W (2006) American gastroenterological association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 130:935–939

    Article  PubMed  Google Scholar 

  18. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963

    PubMed  CAS  Google Scholar 

  19. D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P (1998) Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114:262–267

    Article  PubMed  Google Scholar 

  20. Maconi G, Bollani S, Bianchi Porro G (1996) Ultrasonographic detection of intestinal complications in Crohn’s disease. Dig Dis Sci 41:1643–1648

    Article  PubMed  CAS  Google Scholar 

  21. Gareen IF, Gatsonis C (2003) Primer on multiple regression models for diagnostic imaging research. Radiology 229:305–310

    Article  PubMed  Google Scholar 

  22. Campbell MJ, Machin D (1999) Medical statistics, a commonsense approach. Wiley, Chichester

    Google Scholar 

  23. Sistrom CL, Garvan CW (2004) Proportions, odds, and risk. Radiology 230:12–19

    Article  PubMed  Google Scholar 

  24. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845

    Article  PubMed  CAS  Google Scholar 

  25. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35

    Article  PubMed  CAS  Google Scholar 

  26. Wong DD, Forbes GM, Zelesco M, Mason R, Pawlik J, Mendelson RM (2012) Crohn’s disease activity: quantitative contrast-enhanced ultrasound assessment. Abdom Imaging 37:369–376

    Article  PubMed  Google Scholar 

  27. De Franco A, Marzo M, Felice C et al (2012) Ileal Crohn’s disease: CEUS determination of activity. Abdom Imaging 37:359–368

    Article  PubMed  Google Scholar 

  28. Ripollés T, Martínez-Pérez MJ, Blanc E et al (2011) Contrast-enhanced ultrasound (CEUS) in Crohn’s disease: technique, image interpretation and clinical applications. Insights Imaging 2:639–652

    Article  PubMed  Google Scholar 

  29. Quaia E, De Paoli L, Stocca T, Cabibbo B, Casagrande F, Cova MA (2012) The value of small bowel wall contrast enhancement after sulphur hexafluoride-filled microbubble injection to differentiate inflammatory from fibrotic strictures in patients with Crohn’s disease. Ultrasound Med Biol 38:1324–1332

    Article  PubMed  Google Scholar 

  30. Quaia E, Migaleddu V, Baratella E et al (2009) The diagnostic value of small bowel wall vascularity after sulphur hexafluroride-filled microbubble injection in patients with Crohn’s disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 69:438–444

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Cattinara Hospital, University of Trieste, Strada di Fiume 447, 34149, Trieste, Italy

    Emilio Quaia, Biagio Cabibbo, Luca De Paoli, William Toscano, Gabriele Poillucci & Maria Assunta Cova

Authors
  1. Emilio Quaia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Biagio Cabibbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luca De Paoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William Toscano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabriele Poillucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Assunta Cova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emilio Quaia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quaia, E., Cabibbo, B., De Paoli, L. et al. The value of time-intensity curves obtained after microbubble contrast agent injection to discriminate responders from non-responders to anti-inflammatory medication among patients with Crohn’s disease. Eur Radiol 23, 1650–1659 (2013). https://doi.org/10.1007/s00330-012-2754-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-012-2754-1

Keywords

Search

Navigation